Tag: Research
-
Heart Disease, Racial Disparities and COVID-19
Northwestern Medicine cardiovascular experts discuss how racial disparities, including lower socioeconomic status and pre-existing cardiovascular conditions, can lead African-Americans to be at higher risk for contracting and dying from COVID-19.
-
Unraveling the Cellular Mechanisms Behind Inflammation
A team of investigators have uncovered the cellular mechanisms of a specialized group of white blood cells that help promote the development of inflammatory diseases, according to recent findings.
-
New Insights in Liver Zonation
A new Northwestern Medicine study has shed light on the complex phenomenon of liver zonation, showing that a protein known as Wnt is required for correct placement of tight junction and cell adhesion proteins within the liver.
-
Using Genomics to Understand the Severity of Bacterial Infections
Northwestern Medicine investigators have uncovered a novel pathogenic mechanism used by the bacterium Pseudomonas aeruginosa to promote more severe infections.
-
Study Finds Broad Therapeutic Potential for Nanoparticles
Nanoparticles traveled to different organs in the body depending on the type of protein coating applied, according to a recent study.
-
Sex May Influence Effectiveness of Common Heart Failure Drug
A novel heart failure drug called sacubitril-valsartan reduced the risk of hospitalizations for heart failure and death from cardiovascular causes more in women than in men, according to a study published in Circulation.
-
Centrioles Aid Cellular Migration
A new study has found cells with high numbers of centrioles more quickly migrated through layers of tissue, a process known as radial intercalation, which may provide new insights into the development of many cancers.
-
New Insights into Chromosome Folding
A new study has helped solve the mystery of how dysfunctional chromosome folding leads to cancer.
-
Elevated Gene Expression Linked to Poor Glioblastoma Survival
The elevated expression of a gene called LY6K was correlated with increased cancer cell growth and resistance to radiation therapy in glioblastoma, according to a recent Northwestern Medicine study.
-
COVID-19 Drug Trial Launches at Northwestern Medicine
Northwestern Medicine has enrolled its first participants in a new international clinical drug trial for COVID-19, testing remdesivir, a novel anti-viral drug developed to treat Ebola, and which has also shown antiviral activity in coronaviruses.
